TMEM161B and esophageal squamous cell carcinoma: Furthermore, TMEM161B‐AS1 expression in ESCC patients with III and IV stage as well as lymph node metastasis was dramatically lower than that in ESCC patients with I and II stage as well as without lymph node metastasis (P < .01; Figure 1C,D).